Related Experiment Video
Updated: May 15, 2026

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
Published on: December 8, 2023
Improved survival over the last decade in pediatric patients requiring dialysis after hematopoietic cell
Jurat S Rajpal1, Niharika Patel, Rachel I Vogel
1Divisions of Pediatric Nephrology and Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455, USA.
Insights
Dialysis is a common complication after pediatric hematopoietic cell transplantation (HCT), with stable incidence over two decades. Survival for children needing dialysis post-HCT significantly improved in the 2000s compared to the 1990s.
Area of Science:
- Pediatric Hematology
- Nephrology
- Transplantation Medicine
Background:
- Fluid and electrolyte management often necessitates dialysis in pediatric patients post-hematopoietic cell transplantation (HCT).
- Previous research indicates high mortality rates for children requiring dialysis after HCT, necessitating updated data.
- Recent trends in dialysis incidence and outcomes following pediatric HCT are not well-documented.
Purpose of the Study:
- To compare the incidence of dialysis in children undergoing HCT between two distinct decades (1990-1999 and 2000-2009).
- To evaluate and compare the survival rates of pediatric HCT patients who required dialysis across these two decades.
Main Methods:
- A retrospective review of 1427 pediatric patients (<21 years) undergoing their first HCT between 1990 and 2009 at the University of Minnesota.
- Analysis of prospectively collected data from an institutional HCT database to determine dialysis incidence within 100 days post-HCT and 1-year survival.
- Statistical comparisons included chi-squared tests, Fisher exact tests, Kaplan-Meier survival estimates, log-rank tests, and Cox regression analyses.
Main Results:
- The incidence of dialysis post-HCT remained consistent between the two decades (8.2% in 1990-1999 vs. 8.9% in 2000-2009; P = .6326).
- Patients requiring dialysis in the 2000-2009 cohort demonstrated significantly improved 1-year survival compared to the 1990-1999 cohort (23% vs. 11%; P < .0001).
- Multivariate analysis identified older age, primary disease, pulmonary hemorrhage, and HCT during 1990-1999 as mortality predictors in dialyzed patients; cyclosporine use correlated with better survival.
Conclusions:
- Dialysis is a persistent complication of pediatric HCT, with its incidence unchanged over the past two decades.
- Survival outcomes for pediatric HCT patients requiring dialysis have significantly improved in the more recent decade (2000-2009).
- Despite improvements, mortality remains higher in pediatric HCT patients requiring dialysis compared to those who do not.
Abstract:
It is not unusual for children to require dialysis for fluid and electrolyte management after hematopoietic cell transplantation (HCT). Previous studies have documented high mortality in children who require dialysis after HCT, but recent data are lacking. The purpose of this study was to compare the incidence of dialysis after pediatric HCT and the survival of patients who received dialysis in 2 decades, 1990-1999 and 2000-2009. A total of 1427 patients age <21 years who underwent a first HCT at the University of Minnesota between January 1990 and December 2009 were reviewed using prospectively collected data from the institutional HCT database. The incidence of dialysis during the first 100 days post-HCT and survival at 1 year post-HCT in the 2 cohorts were determined. Comparisons between patients who did and did not require dialysis were made using the χ(2) and Fisher exact tests as appropriate. Kaplan-Meier estimates and 95% confidence intervals for 1-year post-HCT overall survival were reported by dialysis group and compared using the log-rank test. Predictors of overall survival among patients requiring dialysis were assessed using univariate and multivariate Cox regression analyses. The incidence of dialysis was not significantly different in the 2 cohorts (8.2% for 1990-1999 versus 8.9% for 2000-2009; P = .6326). Patients requiring dialysis were significantly more likely to survive to or past 1 year in the 2000-2009 cohort compared with the 1990-1999 cohort (23% versus 11%; P < .0001). Multivariate analyses found that older age at the time of HCT, primary disease type, pulmonary hemorrhage, and HCT in 1990-1999 were associated with increased mortality in the dialyzed population. The use of cyclosporine was associated with increased survival in the patients who received dialysis. Dialysis is an important complication of pediatric HCT with an incidence that has remained constant over the last 2 decades. Survival was improved in the 2000-2009 cohort regardless of dialysis status. Despite a recent significant reduction in mortality in patients requiring dialysis, mortality remains higher in these patients than in those who do not need dialysis.
More Related Videos
08:32CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Kidney Transplant I: Introduction
Hemodialysis I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Hemodialysis II: Procedure and Complications
Kidney Transplant II: Surgical Procedure